CNVY · Convey Health Solutions Holdings, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2021 |
|---|---|
| Revenue | $282.91M |
| Cost of Revenue | - |
| Gross Profit | - |
| R&D | - |
| SG&A | $79.95M |
| Total Operating Expenses | $272.46M |
| D&A | $28.03M |
| Operating Income | $10.45M |
| Interest Expense | $18.86M |
| Income Tax | ($1.90M) |
| Net Income | ($6.46M) |
| EPS - Basic | ($0.11) |
| EPS - Diluted | ($0.11) |
Balance Sheet
| Line item | FY 2021 |
|---|---|
| Cash & Equivalents | $21.46M |
| Accounts Receivable | $62.81M |
| Inventory | $14.06M |
| Accounts Payable | $13.87M |
| Current Assets | $132.25M |
| Total Assets | $829.90M |
| Current Liabilities | $70.40M |
| Long-term Debt | $189.64M |
| Total Liabilities | $292.15M |
| Stockholders' Equity | $171.02M |
| Retained Earnings | ($33.27M) |
Cash Flow
| Line item | FY 2021 |
|---|---|
| Operating Cash Flow | $31.56M |
| Investing Cash Flow | ($13.27M) |
| Financing Cash Flow | $9.43M |
| CapEx | $5.16M |
| Free Cash Flow | $26.40M |
Ratios
| Metric | FY 2021 |
|---|---|
| Profitability | |
| Gross margin | - |
| Operating margin | 3.7% |
| EBITDA margin | 13.6% |
| Net margin | -2.3% |
| Free cash flow margin | 9.3% |
| FCF / Net income | -4.09 |
| R&D / Revenue | - |
| SG&A / Revenue | 28.3% |
| Effective tax rate | - |
| Return on assets | -0.8% |
| Return on equity | -3.8% |
| Return on invested capital | 2.3% |
| Liquidity | |
| Current ratio | 1.88 |
| Quick ratio | 1.68 |
| Cash ratio | 0.30 |
| Leverage | |
| Debt / Equity | 1.11 |
| Debt / Assets | 0.23 |
| Debt / EBITDA | 4.93 |
| Interest coverage | 0.6x |
| Equity multiplier | 4.85 |
| Liabilities / Assets | 0.35 |
| Efficiency | |
| Asset turnover | 0.34 |
| Inventory turnover | - |
| Days sales outstanding | 81d |
| Days inventory outstanding | - |
| Days payable outstanding | - |
| Cash conversion cycle | - |
| Valuation | |
| P / E | - |
| P / B | - |
| P / S | - |
| EV / EBITDA | - |
| Growth | |
| Revenue growth (YoY) | - |
| Revenue CAGR (3y) | - |
| Revenue CAGR (5y) | - |
| Gross profit growth (YoY) | - |
| Operating income growth (YoY) | - |
| Net income growth (YoY) | - |
| EPS growth (YoY) | - |
| EPS CAGR (3y) | - |
| EPS CAGR (5y) | - |
| FCF growth (YoY) | - |
| FCF CAGR (5y) | - |
| Book value growth (YoY) | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Business segments
$337.60M totalTechnology Enabled Solutions$284.62M · 84.3%
Advisory Services$52.98M · 15.7%
Product / service
$462.19M totalService$177.57M · 38.4%
Product$160.02M · 34.6%
Health Care$93.15M · 20.2%
Technology Service$13.77M · 3.0%
Data Analytics$11.66M · 2.5%
Consulting$6.02M · 1.3%
Stability scores
Altman Z′
FY 2021 · bankruptcy risk
0.64
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2021 · 9-point quality
2/9
Weak
- ✗Net income positive
- ✓Operating cash flow positive
- -ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- -Current ratio improved
- -No share dilution
- -Gross margin improved
- -Asset turnover improved
Peer comparison
Same SIC group: Services-Misc Health & Allied Services, NEC
Comparing Convey Health Solutions Holdings against the 5 most active filers in the same SIC group.